The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies.

PubWeight™: 2.10‹?› | Rank: Top 2%

🔗 View Article (PMC 3648152)

Published in J Virol on March 06, 2013

Authors

Stefanie Gierer1, Stephanie Bertram, Franziska Kaup, Florian Wrensch, Adeline Heurich, Annika Krämer-Kühl, Kathrin Welsch, Michael Winkler, Benjamin Meyer, Christian Drosten, Ulf Dittmer, Thomas von Hahn, Graham Simmons, Heike Hofmann, Stefan Pöhlmann

Author Affiliations

1: Infection Biology Unit, German Primate Center, Göttingen, Germany.

Articles citing this

State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans. PLoS Curr (2013) 3.41

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature (2013) 3.00

Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc Natl Acad Sci U S A (2013) 1.73

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proc Natl Acad Sci U S A (2015) 1.64

Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev (2015) 1.64

Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development. J Virol (2013) 1.57

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution. Proc Natl Acad Sci U S A (2014) 1.54

Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies. J Virol (2013) 1.34

Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc Natl Acad Sci U S A (2014) 1.27

Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J Virol (2013) 1.26

Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection. J Virol (2014) 1.25

Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses. J Infect Dis (2013) 1.23

A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines. PLoS One (2013) 1.22

Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J Virol (2013) 1.21

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci U S A (2014) 1.20

Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation. PLoS One (2013) 1.19

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol J (2013) 1.19

Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia. Emerg Infect Dis (2013) 1.15

The emergence of the Middle East respiratory syndrome coronavirus. Pathog Dis (2014) 1.14

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines. Vaccine (2014) 1.13

Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice. PLoS Pathog (2013) 1.09

The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses. J Virol (2014) 1.05

Proteolytic activation of the porcine epidemic diarrhea coronavirus spike fusion protein by trypsin in cell culture. J Virol (2014) 1.01

Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antiviral Res (2013) 0.98

Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus. Proc Natl Acad Sci U S A (2015) 0.97

High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus. J Virol (2015) 0.96

A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. MBio (2014) 0.95

Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms. J Virol (2013) 0.93

Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J (2014) 0.92

Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Res (2014) 0.92

Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov (2016) 0.91

Middle East Respiratory Syndrome. N Engl J Med (2017) 0.91

IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms. Viruses (2014) 0.89

DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry. J Virol (2014) 0.88

Emergence of the Middle East respiratory syndrome coronavirus. PLoS Pathog (2013) 0.86

TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol (2013) 0.86

TMPRSS2 is an activating protease for respiratory parainfluenza viruses. J Virol (2013) 0.86

Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus. Immunology (2015) 0.86

The Middle East respiratory syndrome--how worried should we be? MBio (2013) 0.84

Future treatment strategies for novel Middle East respiratory syndrome coronavirus infection. Future Med Chem (2013) 0.84

Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res (2015) 0.83

Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors. Antiviral Res (2013) 0.82

A camel-derived MERS-CoV with a variant spike protein cleavage site and distinct fusion activation properties. Emerg Microbes Infect (2016) 0.81

Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976. J Infect Dis (2015) 0.81

A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform. J Virol (2015) 0.81

Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol (2016) 0.80

Fusion of Enveloped Viruses in Endosomes. Traffic (2016) 0.80

The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent. PLoS One (2016) 0.79

Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells. J Gen Virol (2015) 0.79

Comparative analysis of the activation of unfolded protein response by spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus HKU1. Cell Biosci (2014) 0.78

Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ. Oncotarget (2017) 0.77

Identification of nafamostat as a potent inhibitor of Middle East respiratory syndrome (MERS) corona virus S-mediated membrane fusion using the split protein-based cell-cell fusion assay. Antimicrob Agents Chemother (2016) 0.77

The amino acids 736-761 of the MERS-CoV spike protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents. Viral Immunol (2014) 0.77

Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry. J Virol (2016) 0.77

Membrane ectopeptidases targeted by human coronaviruses. Curr Opin Virol (2014) 0.76

TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells. PLoS One (2015) 0.75

Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion. J Virol (2016) 0.75

Coronavirus and influenza virus proteolytic priming takes place in tetraspanin-enriched membrane microdomains. J Virol (2015) 0.75

Cell Entry of Porcine Epidemic Diarrhea Coronavirus Is Activated by Lysosomal Proteases. J Biol Chem (2016) 0.75

Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion. J Virol (2017) 0.75

Identification of the Fusion Peptide-Containing Region in Betacoronavirus Spike Glycoproteins. J Virol (2016) 0.75

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A (2017) 0.75

Articles cited by this

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med (2012) 22.75

Bats are natural reservoirs of SARS-like coronaviruses. Science (2005) 13.44

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science (2003) 12.59

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature (2007) 9.52

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature (2003) 8.77

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci U S A (2005) 8.52

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science (2005) 7.07

Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol (2008) 5.26

Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis (2013) 5.25

Severe acute respiratory syndrome. Nat Med (2004) 4.75

Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A (1998) 4.33

Virus membrane-fusion proteins: more than one way to make a hairpin. Nat Rev Microbiol (2006) 4.16

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A (2005) 4.07

Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBO J (1988) 3.98

Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio (2012) 3.96

Human aminopeptidase N is a receptor for human coronavirus 229E. Nature (1992) 3.91

Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc Natl Acad Sci U S A (1991) 3.70

The pH independence of mammalian retrovirus infection. J Gen Virol (1990) 3.68

Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol (2000) 3.46

Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect (2012) 3.22

DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology (2003) 3.20

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A (2004) 3.03

Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol (2006) 2.80

Ecology of zoonoses: natural and unnatural histories. Lancet (2012) 2.71

Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill (2013) 2.39

Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proc Natl Acad Sci U S A (1988) 2.24

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A (2005) 2.21

Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol (2004) 1.80

Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice. AIDS Res Hum Retroviruses (2003) 1.73

Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein. J Virol (1994) 1.68

TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells. J Virol (2010) 1.66

The novel human coronaviruses NL63 and HKU1. J Virol (2006) 1.59

TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Oncogene (2007) 1.58

Multiple organ infection and the pathogenesis of SARS. J Exp Med (2005) 1.58

Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses (2012) 1.55

Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors. J Virol (2006) 1.49

Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol (2010) 1.44

Persistent infection promotes cross-species transmissibility of mouse hepatitis virus. J Virol (1999) 1.44

Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol (2011) 1.44

A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol (2010) 1.40

Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J Virol (2008) 1.37

Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol (2011) 1.37

Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2. J Virol (2004) 1.36

Structural bases of coronavirus attachment to host aminopeptidase N and its inhibition by neutralizing antibodies. PLoS Pathog (2012) 1.34

Entry pathway of vesicular stomatitis virus into different host cells. J Gen Virol (1987) 1.31

A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC. J Infect (2012) 1.28

Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One (2012) 1.24

Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence. Viruses (2012) 1.18

Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis (2004) 1.18

Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion. J Virol (2007) 1.10

Protease-mediated entry via the endosome of human coronavirus 229E. J Virol (2008) 1.09

Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J Virol (2012) 1.04

Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J Virol (2009) 0.94

Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus. Cell Mol Life Sci (2004) 0.93

Severe acute respiratory syndrome-related diarrhea. J Gastroenterol Hepatol (2005) 0.82

Development of novel entry inhibitors targeting emerging viruses. Expert Rev Anti Infect Ther (2012) 0.82

Acute renal failure in patients with severe acute respiratory syndrome. J Formos Med Assoc (2005) 0.77

Articles by these authors

Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature (2007) 9.52

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis (2013) 7.83

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39

Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis (2013) 5.25

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol (2013) 4.98

Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis (2013) 4.87

Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol (2002) 4.63

Bats host major mammalian paramyxoviruses. Nat Commun (2012) 4.15

Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio (2012) 3.96

Transmission of MERS-coronavirus in household contacts. N Engl J Med (2014) 3.81

Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis (2014) 3.74

Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology (2010) 3.64

Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis (2013) 3.61

Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis (2014) 3.25

DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology (2003) 3.20

Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences. J Virol (2010) 3.01

Detection and prevalence patterns of group I coronaviruses in bats, northern Germany. Emerg Infect Dis (2008) 3.00

A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood (2005) 2.90

Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis (2009) 2.86

Circulation of group 2 coronaviruses in a bat species common to urban areas in Western Europe. Vector Borne Zoonotic Dis (2010) 2.65

A novel rhabdovirus associated with acute hemorrhagic fever in central Africa. PLoS Pathog (2012) 2.63

Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion (2002) 2.53

Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana. Emerg Infect Dis (2009) 2.52

Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol (2002) 2.46

Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol (2003) 2.42

Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation. N Engl J Med (2014) 2.39

Circulation of 3 lineages of a novel Saffold cardiovirus in humans. Emerg Infect Dis (2008) 2.35

Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis (2008) 2.29

Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28

The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J Biol Chem (2007) 2.24

Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell (2007) 2.22

Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J Infect Dis (2007) 2.22

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A (2005) 2.21

Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg Infect Dis (2010) 2.19

Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio (2013) 2.17

Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol (2007) 2.16

Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J Virol (2004) 2.15

RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene. Trans R Soc Trop Med Hyg (2007) 2.10

Henipavirus RNA in African bats. PLoS One (2009) 2.10

High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013. Trop Med Int Health (2015) 2.09

Diverse CD81 proteins support hepatitis C virus infection. J Virol (2006) 2.07

Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J Infect Dis (2013) 2.06

Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol (2009) 2.05

Amplification of emerging viruses in a bat colony. Emerg Infect Dis (2011) 1.98

Chikungunya fever in travelers: clinical presentation and course. Clin Infect Dis (2007) 1.93

DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol (2004) 1.92

Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis (2003) 1.91

No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science (2011) 1.90

Management of major postsurgical gastroesophageal intrathoracic leaks with an endoscopic vacuum-assisted closure system. Gastrointest Endosc (2009) 1.89

Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis (2014) 1.89

Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray. J Clin Microbiol (2007) 1.89

Hepatic gas gangrene following liver transplantation. Liver Transpl (2007) 1.85

One century of aryne chemistry. Angew Chem Int Ed Engl (2003) 1.81

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol (2004) 1.80

Prevalence, types, and RNA concentrations of human parechoviruses, including a sixth parechovirus type, in stool samples from patients with acute enteritis. J Clin Microbiol (2007) 1.79

Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells. J Virol (2002) 1.78

The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response. Blood (2009) 1.78

Spectrum of viruses and atypical bacteria in intercontinental air travelers with symptoms of acute respiratory infection. J Infect Dis (2007) 1.75

Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol (2004) 1.74

High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J Virol (2007) 1.73

RBP-Jkappa/SHARP recruits CtIP/CtBP corepressors to silence Notch target genes. Mol Cell Biol (2005) 1.72

Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect (2002) 1.71

MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg Infect Dis (2014) 1.71

Superinfection exclusion in cells infected with hepatitis C virus. J Virol (2007) 1.71

The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses. J Immunol (2010) 1.70

Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae. J Virol (2012) 1.69

TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells. J Virol (2010) 1.66

CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity. J Virol (2002) 1.66

Crimean-Congo hemorrhagic fever in Kosovo. J Clin Microbiol (2002) 1.64

Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma. PLoS Negl Trop Dis (2009) 1.63

Studying hepatitis C virus: making the best of a bad virus. J Virol (2007) 1.62

Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis (2006) 1.62

Natural regulatory T cells and persistent viral infection. J Virol (2007) 1.62

Hantavirus in bat, Sierra Leone. Emerg Infect Dis (2012) 1.60

Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology (2007) 1.59

Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J Virol (2006) 1.59

Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology (2009) 1.59

Open reading frame UL26 of human cytomegalovirus encodes a novel tegument protein that contains a strong transcriptional activation domain. J Virol (2002) 1.57

BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection. Blood (2013) 1.57

Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection. Eur J Immunol (2006) 1.56

Evidence for novel hepaciviruses in rodents. PLoS Pathog (2013) 1.54

Coronavirus antibodies in African bat species. Emerg Infect Dis (2007) 1.54

Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis (2007) 1.53

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology (2011) 1.52

A novel diagnostic target in the hepatitis C virus genome. PLoS Med (2009) 1.52

Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus. J Virol (2007) 1.50